Format

Send to

Choose Destination
J Med Toxicol. 2019 Oct;15(4):228-254. doi: 10.1007/s13181-019-00736-9. Epub 2019 Oct 22.

The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report.

Author information

1
Department of Emergency Medicine, Division of Medical Toxicology, University of Southern California, 1200 N State St. Rm 1011, Los Angeles, CA, 90033, USA. mspyres@gmail.com.
2
Hartford Hospital and University of Connecticut School of Medicine, 80 Seymour Street, Hartford, CT, 06102, USA.
3
Departments of Medicine and Child Health, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA.
4
Department of Medical Toxicology, Banner-University Medical Center, 1012 E Willetta Street, Fl 2, Phoenix, AZ, 85006, USA.
5
New Jersey Medical School, Rutgers, The State University of New Jersey, 140 Bergen Street, Suite G1600, Newark, NJ, 07101-1709, USA.
6
American College of Medical Toxicology, 10645 N Tatum Blvd., Suite 200-111, Phoenix, AZ, 85028, USA.
7
University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA, 15213, USA.
8
University of Rochester Medical Center and Strong Memorial Hospital, 601 Elmwood Ave, Rochester, NY, 14642, USA.
9
Indiana university school of medicine, 340 West 10th Street, Suite 6200, Indianapolis, IN, 46202, USA.
10
Michigan State University College of Human Medicine, 100 Michigan NE MC49, Grand Rapids, MI, 49503, USA.
11
University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX, 75390, USA.
12
University of Colorado School of Medicine, 13001 E 17th Pl, Aurora, CO, 80045, USA.

Abstract

The Toxicology Investigators Consortium (ToxIC) Registry was established by the American College of Medical Toxicology (ACMT) in 2010. The Registry collects data from participating sites with the agreement that all bedside medical toxicology consultation will be entered. The objective of this ninth annual report is to summarize the Registry's 2018 data and activity with its additional 7043 cases. Cases were identified for inclusion in this report by a query of the ToxIC database for any case entered from 1 January to 31 December 2018. Detailed data was collected from these cases and aggregated to provide information which included demographics, reason for medical toxicology evaluation, agent and agent class, clinical signs and symptoms, treatments and antidotes administered, mortality, and whether life support was withdrawn. A total of 51.5% of cases were female, 48% were male, and 0.6% transgender. Non-opioid analgesics were the most commonly reported agent class, followed by antidepressants and opioids. Acetaminophen was once again the most common agent reported. There were 106 fatalities, comprising 1.5% of all registry cases. Major trends in demographics and exposure characteristics remained similar to past years' reports. Sub-analyses were conducted to describe exposures in elderly patients, addiction consultation practices, and risk factors for bupropion-induced seizures. The launch of the ToxIC Qualified Clinical Data Registry (TQCDR) is also described.

KEYWORDS:

Epidemiology; Medical Toxicology; Overdose; Poisoning; Surveillance

PMID:
31642014
PMCID:
PMC6825068
[Available on 2020-10-01]
DOI:
10.1007/s13181-019-00736-9

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center